WallStreetZenWallStreetZen

NASDAQ: PCSA
Processa Pharmaceuticals Inc Stock Ownership - Who owns Processa Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Processa Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Patrick LinChief Business - Strategy Off2025-04-014,814$0.41
$1.98kSell
Sian BigoraChief Development Officer2025-04-013,311$0.41
$1.36kSell
David 1. YoungPres. Research Development2025-04-015,345$0.41
$2.20kSell
David 1. YoungPres. Research Development2025-01-27124,500$0.80
$99.23kBuy
George K. NgChief Executive Officer2025-01-2787,200$0.80
$69.50kBuy
Patrick LinChief Business - Strategy Off2025-01-2743,500$0.80
$34.67kBuy
Justin W. YorkeDirector2025-01-2712,400$0.80
$9.88kBuy

1 of 1

PCSA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PCSA insiders and whales buy or sell their stock.

PCSA Shareholders

What type of owners hold Processa Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Besser2.90%1,458,300$336.87kInsider
Justin W. Yorke2.23%1,124,049$259.66kInsider
George K. Ng0.65%327,200$75.58kInsider
David 1. Young0.55%277,647$64.14kInsider
Virgil Thompson0.48%240,755$55.61kInsider
Khalid Islam0.38%193,395$44.67kInsider
Robert Michael Floyd0.34%172,061$39.75kInsider
Patrick Lin0.16%82,227$18.99kInsider
Geraldine Pannu0.11%57,613$13.31kInsider
Armistice Capital LLC0.11%56,000$12.94kInstitution

1 of 4

PCSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PCSA0.34%8.06%Net Buying
OSRH0.17%99.83%
MLEC3.66%86.24%
NXTC52.31%47.69%
XTLB0.03%12.85%
View Top Biotech Stocks

Processa Pharmaceuticals Stock Ownership FAQ

Who owns Processa Pharmaceuticals?

Processa Pharmaceuticals (NASDAQ: PCSA) is owned by 0.34% institutional shareholders, 8.06% Processa Pharmaceuticals insiders, and 91.60% retail investors. James E. Besser is the largest individual Processa Pharmaceuticals shareholder, owning 1.46M shares representing 2.90% of the company. James E. Besser's Processa Pharmaceuticals shares are currently valued at $338.33k.

If you're new to stock investing, here's how to buy Processa Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.